Evidence map›Paper›PMID 38748290›Full record

ArticleEJNMMI reports2024

Clinical value of semi-quantitative parameters in

Friedrich Weitzer, Susanne Stanzel, Elisabeth Plhak, Reingard Maria Aigner

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. SUV-max ofJournal of neuro-oncology · 2025
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Friedrich WeitzerDepartment of Radiology, Division of Nuclear Medicine Medical, University of Graz, Auenbruggerplatz 9A, 8036, Graz, Austria. friedrich.weitzer@medunigraz.at.ORCID http://orcid.org/0000-0003-3230-8184
Susanne StanzelDepartment of Radiology, Division of Nuclear Medicine Medical, University of Graz, Auenbruggerplatz 9A, 8036, Graz, Austria.
Elisabeth PlhakDepartment of Radiology, Division of Nuclear Medicine Medical, University of Graz, Auenbruggerplatz 9A, 8036, Graz, Austria.
Reingard Maria AignerDepartment of Radiology, Division of Nuclear Medicine Medical, University of Graz, Auenbruggerplatz 9A, 8036, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe value of somatostatin-analogon PET tracers in theranostics in cranial meningioma has been demonstrated in several studies; however, the value of semi-quantitative parameters for therapy and patient outcome is still unclear.

methodsA retrospective study was performed comparing measured semi-quantitative

resultsThirty-two patients from January 2018 to February 2023 were retrospectively included. The WHO grade I meningioma was confirmed in 17 patients, the WHO grade II in five patients, and the WHO grade III in two patients, while in eight patients, diagnosis was solely based on MRI and

conclusionIncreased SUVmax values in the tumor in

Indexed as

68Ga-DOTANOCMeningiomaPET/CTSemi-quantitative parameters

Identifiers

PMID38748290
PMCPMC11045701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.